Note: All regulatory and insurance information in this article pertains specifically to the United States healthcare system. Legal frameworks, reimbursement structures, and licensing arrangements differ substantially in other jurisdictions.
Summary: Concierge medicine represents a growing segment of US primary care characterised by direct physician-patient financial arrangements, reduced panel sizes, and enhanced access. However, concierge medicine is not a single model: direct primary care (DPC), traditional concierge medicine, and boutique medicine differ in meaningful ways regarding insurance interactions, panel structure, and regulatory obligations. This article examines these distinctions and considers the evidence base underpinning concierge models, the regulatory environment governing membership-based primary care and selected treatments offered within it, and the equity and access implications of a model that remains largely inaccessible to lower-income populations. Where outcome data are limited or still emerging, that uncertainty is stated explicitly. The article concludes that while concierge medicine may offer measurable benefits in continuity of care and patient access, its growth raises substantive questions about healthcare stratification and the boundaries of evidence-based practice.
1. Introduction
Over the past two decades, membership-based primary care has expanded considerably within the United States healthcare system, prompted in part by widespread dissatisfaction — among both physicians and patients — with the constraints of volume-driven conventional practice. Physicians in standard primary care settings typically manage between 2,000 and 3,000 active patients,¹ a panel size that substantially limits appointment duration, continuity, and the scope of preventive care that can reasonably be delivered.
Membership-based models seek to address these constraints by restricting panel size — typically to between 300 and 600 patients per physician² — and funding the practice through a recurring fee paid directly by the patient, either in addition to or instead of insurance billing. The resulting model promises longer appointments, more accessible communication, and a closer therapeutic relationship.
Despite increasing uptake, terminology in this space is frequently used loosely, and the distinctions between related models carry genuine clinical and regulatory significance. The following section clarifies those distinctions before examining the evidence base, cost implications, regulatory environment, and broader systemic concerns.
2. Clarifying the Terminology: Concierge Medicine, DPC, and Boutique Medicine
The terms “concierge medicine,” “direct primary care,” “boutique medicine,” and “membership-based primary care” are often used interchangeably in popular discourse, but they describe distinct models with different regulatory and financial implications.
2.1 Direct Primary Care (DPC)
DPC practices charge a periodic membership fee — typically between $50 and $150 per month³ — that covers most primary care services. Critically, DPC practices do not bill insurance for services covered by the membership; the membership fee is the complete payment. This distinguishes DPC from other concierge models both operationally and legally. Under US federal law, DPC arrangements are explicitly excluded from classification as insurance under the Affordable Care Act (ACA) when structured appropriately,⁴ which has important consequences for how patients must structure their broader coverage. Patients enrolled in DPC practices are generally advised to maintain a separate high-deductible health plan (HDHP) for specialist and hospital care.
2.2 Traditional Concierge Medicine
Traditional concierge practices maintain relationships with Medicare and/or commercial insurers for covered services and charge a separate membership fee for enhanced access and non-covered services. The membership fee itself is not covered by Medicare or any standard commercial insurance product.⁵ Panel sizes in this model are typically smaller than in DPC, and membership fees are considerably higher, often ranging from $200 to over $1,000 per month. This model is common among practices serving older adults and high-net-worth populations.
2.3 Boutique Medicine
“Boutique medicine” is an informal descriptor rather than a defined regulatory category. It is generally applied to high-cost concierge practices that offer a broad range of wellness, preventive, and elective services beyond standard primary care, often including advanced diagnostics, aesthetic medicine, and functional medicine interventions. The term carries no specific legal or regulatory meaning in the United States.
3. Care Delivery Models
Within the broad category of membership-based primary care, several care delivery models have emerged:
3.1 Office-Based Concierge Care
The most common model. Concierge doctors in Orange County at Unify Care offer patients the ability to attend a clinic for appointments that are typically longer than those in standard primary care settings. The physician maintains a smaller panel and offers enhanced access, including same-day or next-day appointments and direct communication by phone or electronic message. Some practices operate within the insurance system; others are entirely cash-pay.
3.2 In-Home and House Call Care
Some practices have restructured care around physician home visits, which can benefit patients with mobility limitations, complex chronic conditions, or frailty. The clinical scope of home-delivered care is inherently constrained: routine primary care and certain monitoring tasks are feasible, while more complex diagnostics generally require a facility. The extent to which a given practice can deliver safe, comprehensive care in the home setting should be carefully evaluated, particularly for patients with significant medical complexity.
3.3 Telehealth-Integrated Models
Many concierge practices incorporate both synchronous and asynchronous telehealth as supplements to in-person care. Telehealth expanded significantly following regulatory relaxations during the COVID-19 pandemic, with some of those relaxations extended.⁶ Telehealth is not clinically appropriate for all presentations; its integration into concierge practice varies substantially across practices.
3.4 Functional and Integrative Medicine Models
A subset of concierge practices centres on what is described as a “root cause” or functional medicine approach, emphasising lifestyle, nutritional interventions, hormonal health, and preventive biomarker testing. The evidence base for individual interventions within this category is variable. Some, such as structured lifestyle counselling and evidence-based hormone replacement therapy for documented deficiencies, are well-supported in the literature.⁷ Others, including a range of supplement protocols, regenerative therapies, and advanced IV infusions, are not. Patients and clinicians evaluating such practices should apply the same standards of evidence appraisal as in any other clinical context.
4. The Evidence Base for Concierge Medicine
Research on concierge medicine’s clinical outcomes remains limited in volume and methodological rigour. A number of studies have reported associations between smaller patient panels and longer appointment times, higher patient satisfaction scores, and improved continuity of care.⁸ These findings are consistent with well-established evidence that continuity of care is associated with better health outcomes, lower hospitalisation rates, and reduced mortality.⁹
Whether concierge medicine, as a model, produces measurably superior long-term health outcomes compared with high-quality conventional primary care is a harder question to answer. Selection bias is a substantive methodological challenge: patients who can afford and choose concierge practices may differ from the general population in health literacy, baseline health status, socioeconomic stability, and engagement with preventive care in ways that are difficult to control for in observational studies. Robust randomised controlled evidence does not exist, and is unlikely to be generated at scale given the financial and logistical barriers.
The preventive medicine and lifestyle-based components of many concierge practices have well-established evidence bases in their own right.⁷ However, the mere incorporation of evidence-based preventive strategies into a membership model does not validate the membership model as a whole, and the quality of individual services offered within concierge practices varies considerably.
5. Regulatory Considerations
5.1 Medicare and Insurance Billing
The interaction between concierge practices and federal insurance programmes is an area of ongoing regulatory scrutiny. Physicians participating in Medicare who choose to operate a concierge practice must navigate the requirements of “opting out” or “opting in” with respect to Medicare billing for different service categories. Practices that accept Medicare for covered clinical services while charging a separate membership fee must ensure the membership fee does not cover Medicare-covered services; doing so would constitute a prohibited additional charge under the Medicare Beneficiary Ombudsman guidelines.⁵ Physicians who opt out of Medicare entirely may contract privately with Medicare-eligible patients but must comply with specific disclosure and contracting requirements.
5.2 Selected Treatments: Regulatory Status
Several treatments increasingly offered in concierge and boutique practices warrant particular attention to their regulatory status in the United States.
Exosome-Based Therapies
Exosome-based therapies are an active area of research in regenerative medicine. As of early 2026, the US Food and Drug Administration (FDA) had not approved any exosome product for clinical use outside of a formal clinical trial.¹⁰ The FDA has issued multiple safety warnings regarding the unapproved use of exosome products, citing risks including severe adverse reactions. Clinicians offering exosome therapies outside an approved trial setting are operating outside FDA-approved practice, and patients should be explicitly informed of this regulatory status in advance of any such treatment.
GLP-1 Receptor Agonists for Weight Management
Several GLP-1 receptor agonists — including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) — are FDA-approved for specific indications, including type 2 diabetes and/or obesity management at defined doses.¹¹ Their prescription for indications or at doses outside those approved constitutes off-label use. More significantly, compounded versions of these medications proliferated during periods of drug shortage; the FDA has indicated that compounding of these drugs must cease once shortage designations are lifted, and enforcement actions have followed.¹² Clinicians prescribing GLP-1 medications in the concierge setting should ensure compliance with current FDA guidance on approved formulations and indications, and should conduct appropriate cardiovascular and metabolic risk assessment.
Compounded Bioidentical Hormone Replacement Therapy (cBHRT)
Compounded bioidentical hormone preparations are widely used in functional medicine and concierge practices, but are not subject to the same FDA approval process as manufactured hormone therapies. The FDA has noted that compounded hormone preparations lack the safety and efficacy data required of approved products.¹³ Several major professional societies, including the Endocrine Society, have concluded that there is insufficient evidence to support superiority claims for cBHRT over conventional hormone therapy formulations, and have expressed concerns about unsubstantiated marketing claims.¹⁴ Patients should be clearly informed of the distinction between compounded and FDA-approved preparations.
6. Costs, Access, and Equity
Membership fees at concierge and DPC practices vary widely. DPC models, which serve a broader income demographic, typically charge $50–$150 per month. Traditional concierge practices often charge $250–$500 per month or more; high-end boutique practices may charge considerably above $1,000 per month. These fees represent an out-of-pocket cost paid in addition to, not instead of, most patients’ insurance premiums. For most American households, this additional expense is prohibitive.
The equity implications of concierge medicine’s growth have received increasing attention in the literature on healthcare delivery. Physicians who transition from conventional to concierge practice reduce the capacity available to patients who cannot afford membership fees, which may disproportionately affect lower-income populations, rural communities, and those with Medicaid coverage in areas already experiencing primary care shortages.¹⁵ The American Academy of Family Physicians and related bodies have acknowledged these concerns while also recognising the legitimate role that alternative practice models may play in addressing physician burnout and attrition from primary care.
Patients considering concierge membership should also understand that the fee structure does not replace the need for comprehensive insurance coverage. Specialist referrals, hospital admissions, emergency care, laboratory testing beyond what is included in the membership, and prescription medications are typically not covered by the membership fee and will be subject to normal insurance billing or out-of-pocket payment.
7. Continuity of Care and Structural Limitations
Concierge medicine’s central claim — that smaller panels enable better care — rests substantially on the value of care continuity, which is well-supported in the primary care literature.⁹ However, the model introduces its own continuity risks. If a concierge practice closes, a physician retires or relocates, or a practice undergoes an ownership change, patients may face significant disruption. In some practices, panel sizes are small enough that the departure of a single physician effectively closes the practice. Coverage arrangements for physician absence vary and are not always clearly specified in membership contracts.
Patients entering concierge arrangements should review contract terms carefully, including the duration of the agreement, cancellation conditions, provisions for physician absence or departure, and the handling of medical records on termination of the membership.
8. Physician Credentials and Scope of Practice
The concierge medicine sector is not governed by a single regulatory body, and the range of services offered across practices is wide. Board certification status can be independently verified through the American Board of Medical Specialties (ABMS). Hospital affiliations, if relevant to the practice’s care model, should also be confirmed. Patients should establish whether care will be delivered primarily by a physician, or whether physician assistants or nurse practitioners play a central role — an important distinction that is not always clearly communicated at the point of enrollment.
More broadly, the presence of a membership fee and an attentive initial consultation does not constitute evidence that all treatments offered are evidence-based or regulatory-compliant. Patients and referring clinicians should apply standard evidence appraisal and ask explicitly about the evidence base and regulatory status of any treatment offered that falls outside the mainstream of primary care.
9. Discussion and Conclusions
Concierge medicine, taken broadly, represents a structural response to real and documented deficiencies in conventional US primary care — overcrowded panels, compressed appointment times, and limited continuity of care. The evidence that smaller panels and longer appointments can improve patient experience and care coordination is plausible and consistent with the primary care literature, though robust outcome data specific to the concierge model are limited by methodological constraints.
At the same time, concierge medicine raises substantive concerns that warrant continued analytical attention. The model’s economic structure is inherently stratifying: it improves access for those who can pay while potentially reducing primary care capacity for those who cannot. Its regulatory environment — particularly regarding billing compliance, compounded pharmaceuticals, and unapproved therapies — is incompletely enforced. And its evidence base, particularly in the functional and integrative medicine segments, is uneven in ways that are not always transparent to patients.
The growth of concierge medicine cannot be evaluated in isolation from the broader context of US primary care: chronic workforce shortages, inadequate reimbursement structures for cognitive and preventive care, and high rates of physician burnout are structural conditions that drive physicians toward alternative practice models. These conditions require systemic responses that concierge medicine, by design, does not provide.
For clinicians, policymakers, and healthcare researchers, concierge medicine merits serious and nuanced engagement — neither uncritical enthusiasm nor reflexive dismissal. Its growth reflects genuine patient and physician needs, but its implications for equity, evidence-based practice, and healthcare system integrity deserve sustained scrutiny.
References
- Alexander GC, Kurlander J, Wynia MK. Physicians in retainer (“concierge”) practice. A national survey of physician, patient, and practice characteristics. J Gen Intern Med. 2005 Dec;20(12):1079-83. doi: 10.1111/j.1525-1497.2005.0233.x. PMID: 16423094; PMCID: PMC1490281.
- Rittenhouse DR, Shortell SM. The patient-centered medical home: will it stand the test of health reform? JAMA. 2009 May 20;301(19):2038-40. doi: 10.1001/jama.2009.691. PMID: 19454643.
- Phillips RL Jr, Bazemore AW. Primary care and why it matters for U.S. health system reform. Health Aff (Millwood). 2010 May;29(5):806-10. doi: 10.1377/hlthaff.2010.0020. PMID: 20439865.
- Jackson GL, Powers BJ, Chatterjee R, Bettger JP, Kemper AR, Hasselblad V, et al. The patient-centered medical home: a systematic review. Ann Intern Med. 2013;158(3):169-178. https://utsouthwestern.elsevierpure.com/en/publications/the-patient-centered-medical-home-a-systematic-review/
- Doherty R; Medical Practice and Quality Committee of the American College of Physicians. Assessing the Patient Care Implications of “Concierge” and Other Direct Patient Contracting Practices: A Policy Position Paper From the American College of Physicians. Ann Intern Med. 2015 Dec 15;163(12):949-52. doi: 10.7326/M15-0366. Epub 2015 Nov 10. PMID: 26551655.
- Eskew PM, Klink K. Direct Primary Care: Practice Distribution and Cost Across the Nation. J Am Board Fam Med. 2015 Nov-Dec;28(6):793-801. doi: 10.3122/jabfm.2015.06.140337. PMID: 26546656.
- Pereira Gray DJ, Sidaway-Lee K, White E, Thorne A, Evans PH. Continuity of care with doctors-a matter of life and death? A systematic review of continuity of care and mortality. BMJ Open. 2018 Jun 28;8(6):e021161. doi: 10.1136/bmjopen-2017-021161. PMID: 29959146; PMCID: PMC6042583.
- Cole ES. Direct Primary Care: Applying Theory to Potential Changes in Delivery and Outcomes. J Am Board Fam Med. 2018 Jul-Aug;31(4):605-611. doi: 10.3122/jabfm.2018.04.170214. PMID: 29986986..
- Baker R, Freeman GK, Haggerty JL, Bankart MJ, Nockels KH. Primary medical care continuity and patient mortality: a systematic review. Br J Gen Pract. 2020;70(698):e600-e611. https://bjgp.org/content/70/698/e600
- Brekke G, Onge JS, Kimminau K, Ellis S. Direct primary care: Family physician perceptions of a growing model. Popul Med. 2021 Aug;3:21. doi: 10.18332/popmed/140087. Epub 2021 Aug 2. PMID: 34651142; PMCID: PMC8513742.
- Tou LC, Jeyakumar SJ, Siddiqui TA, Ravi S, Prakash N. Understanding Patient Perceptions Towards Direct Primary Care: A Focus Group Study. J Patient Exp. 2022 Aug 1;9:23743735221117359. doi: 10.1177/23743735221117359. PMID: 35936512; PMCID: PMC9350501.
- Leive A, David G, Candon M. On resource allocation in health care: The case of concierge medicine. J Health Econ. 2023 Jul;90:102776. doi: 10.1016/j.jhealeco.2023.102776. Epub 2023 Jun 1. PMID: 37329669.
- Alhawshani S, Khan S. A literature review on the impact of concierge medicine services on individual healthcare. J Family Med Prim Care. 2024 Jun;13(6):2183-2186. doi: 10.4103/jfmpc.jfmpc_1685_23. Epub 2024 Jun 14. PMID: 39027837; PMCID: PMC11254062.
- Goldstein ND, Yerkes P. Are Direct Primary Care Practices Located in Health Professional Shortage Areas? Ann Fam Med. 2024 Nov-Dec;22(6):522-524. doi: 10.1370/afm.3168. PMID: 39586711; PMCID: PMC11588384.
- Rylands KS, Collins CM, Collins DR Jr. Maximizing the value of concierge medicine: a systematic review of cost, access, and outcomes. Am J Med. 2025;138(9):1201-1213. https://www.sciencedirect.com/science/article/abs/pii/S0002934325001986
Disclaimer: This article is provided for general informational and educational purposes only and does not constitute medical advice, legal advice, regulatory advice, insurance advice, or financial advice. It is focused solely on the United States healthcare system, and the laws, regulations, reimbursement policies, licensing requirements, and payer arrangements discussed may change over time and may not apply in other jurisdictions. While every effort has been made to present accurate and up-to-date information at the time of publication, Open MedScience makes no representation or warranty as to the completeness, accuracy, or ongoing currency of the material. References to treatments, care models, regulatory issues, or clinical practices should not be understood as endorsements, recommendations, or confirmations of safety, efficacy, or legal compliance. Patients should seek advice from a qualified physician or other appropriately licensed healthcare professional before making decisions about medical care, and clinicians or organisations should obtain advice from qualified legal, regulatory, billing, or compliance professionals before relying on any part of this article in practice.
home » blog » health matters »
